Read More Pharma Industry News Nura Bio kicks off Phase 1 clinical trials for SARM1 inhibitor NB-4746 Nura Bio, a leading biopharmaceutical company specializing in neuroprotective, small molecule therapies, announced today the initiation of Phase… byPallavi MadhirajuAugust 25, 2023